Differential regulation of the p70 S6 kinase pathway by interferon α (IFNα) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells

The precise mechanisms by which imatinib mesylate (STI571) and interferon α (IFNα) exhibit antileukemic effects are not known. We examined the effects of IFNs or imatinib mesylate on signaling pathways regulating initiation of mRNA translation in BCR-ABL-expressing cells. Treatment of IFN-sensitive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Parmar, Simrit, Smith, Jessica, Sassano, Antonella, Uddin, Shahab, Katsoulidis, Efstratios, Majchrzak, Beata, Kambhampati, Suman, Eklund, Elizabeth A., Tallman, Martin S., Fish, Eleanor N., Platanias, Leonidas C.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society of Hematology 2005
Materias:
Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895266/
https://ncbi.nlm.nih.gov/pubmed/15790787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2004-10-4003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares